GILEAD SCIENCES, INC. (GILD)
Clinical trial NCT06630299 updates: 1. primary completion date: 2026-04-01 → 2026-04-23 2. enrollment: not set → 600 participants
Clinical trial NCT06630299 updates: 1. primary completion date: 2026-04-01 → 2026-04-23 2. enrollment: not set → 600 participants
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical